MCL1 and neoplasm: However, only a few reports exist on the use of ABT-263 or ABT-737 in hypoxic tumor models [15, 16], and as pointed out by Harrison and co-workers [16], whether Mcl-1 is up- or down-regulated may be cell type- and oxygen concentration-dependent.